Table 1 Clinical characteristics and demographics of study participants.

From: Dysregulated gene expression associated with inflammatory and translation pathways in activated monocytes from children with autism spectrum disorder

 

TD (n = 22)

AD (n = 17)

PDDNOS (n = 9)

M/F

18/4

13/4

7/2

 

Mean ± SE

Range

Mean ± SE

Range

Mean ± SE

Range

Age

5.7 ± 0.3

4.5-9.2

5.7 ± 0.2

4.7-7.4

6.6 ± 0.4

4.7-7.9

MSEL DQ

105.0 ± 2.5

80.3-129.6

42.5 ± 4.8

19.7-88.7

67.7 ± 8.5

34.5-117

MSEL VDQ

103.6 ± 2.8

79.2-129.7

70.1 ± 4.0

41.3-111.3

72.3 ± 6.5

48.7-107.1

MSEL NVDQ

103.8 ± 2.2

82.3-126.9

56.3 ± 4.1

36.2-100.0

70.0 ± 7.2

43.1-107.4

ADOS RBB

NA

NA

4.6 ± 0.4

2-8

4.0 ± 0.6

1-6

ADOS SA

NA

NA

15.1 ± 3.2

9-20

11.0 ± 3.6

5-16

ADOS Severity

NA

NA

8.4 ± 1.7

5-10

6.4 ± 1.7

4-10

 

TD (n = 22)

AD (n = 17)

PDDNOS (n = 9)

GI scores (n=)

0/1

2+

0/1

2+

0/1

2+

Constipation

22

0

10

7

7

2

Diarrhea

21

1

14

3

8

1

Both (D+C)

22

0

13

4

8

1

  1. AD Autistic Disorder, ADOS Autism Diagnostic Observation Schedule, DQ Developmental Quotient, MSEL Mullen Scales of Early Learning, NDQ Nonverbal Developmental Quotient, PDDNOS Pervasive Developmental Disorder Not Otherwise Specified, RBB Restricted and Repetitive Behavior, SA Social Affect, TD Typically Developing, VDQ Verbal Developmental Quotient.
Back to article page